DNAnexus has hired David Shaywitz to be its chief medical officer.
Shaywitz joins DNAnexus from Theravance Biopharma where he focused on strategy and business development, and led a product team. Prior to that, he was a management
consultant at the Boston Consulting Group, and was a member of the department of experimental medicine at Merck Research Labs. He is also a co-founder of the Pasteur translational research program at Harvard Medical School; and a founding advisor of Sage Bionetworks.